The company is dedicating more funds to research, development and innovative projects.
The deal will help strengthen the Edwards portfolio of smart monitoring technologies.
The union will strengthen BD’s leadership in medication management and infection prevention, and increase opportunities in fast-growing clinical areas and OUS markets.
The company is performing well across all business units and geographies.
Foreign device companies can expect a big opportunity for expansion in Southeast Asia.
The deal creates the largest global sterilization and lab services operation.
Shift the odds in your favor.
Trends in mHealth to be driven by increased smartphone penetration and prevalence of chronic diseases.
Expect to see slow growth and more mergers & acquisitions.
Companies recruiting Asian executives need to do double the due diligence than is customary for hiring a Western executive.